Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'RIBRAG V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fenaux, P; Bourhis, JH; Ribrag, V
      Burkitt's acute lymphocytic leukemia (L(3)ALL) in adults

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    2. Ribrag, V; Hajj, ME; Janot, F; Girinsky, T; Domenge, C; Schwaab, G; Fenaux, P; Bosq, J
      Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

      LEUKEMIA
    3. Soussain, C; Suzan, F; Hoang-Xuan, K; Cassoux, N; Levy, V; Azar, N; Belanger, C; Achour, E; Ribrag, V; Gerber, S; Delattre, JY; Leblond, V
      Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    4. Girinsky, T; Guillot-Vals, D; Koscielny, S; Cosset, JM; Ganem, G; Carde, P; Monhonval, M; Pereira, R; Bosq, J; Ribrag, V; Vantelon, JM; Munck, JN
      A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: Analysis of predictive parameters of response to treatment

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    5. Vantelon, JM; Munck, JN; Bourhis, JH; Pico, JL; Fadel, C; Ulusakarya, A; Carde, P; Fenaux, P; Ribrag, V
      Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy

      BONE MARROW TRANSPLANTATION
    6. Suzan, F; Ammor, M; Ribrag, V
      Fatal reactivation of cytomegalovirus infection after use of rituximab fora post-transplantation lymphoproliferative disorder.

      NEW ENGLAND JOURNAL OF MEDICINE
    7. Ribrag, V; Bibeau, F; El Weshi, A; Frayfer, J; Fadel, C; Cebotaru, C; Laribi, K; Fenaux, P
      Primary breast lymphoma: a report of 20 cases

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Ribrag, V; Raymond, E
      The concept of time in delivering a medication: the case of anticancer agents

      M S-MEDECINE SCIENCES
    9. Vantelon, JM; Koscielny, S; Brault, P; Bourhis, JH; Ribrag, V; Pico, J; Fenaux, P; Munck, JN
      Scoring system for the prediction of successful peripheral blood stem cell(PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinicalpractice

      BONE MARROW TRANSPLANTATION
    10. KEPKA L; DELASSENCE A; RIBRAG V; GACHOT B; BLOT F; THEODORE C; BONNAY M; KORENBAUM C; NITENBERG G
      SUCCESSFUL RESCUE IN A PATIENT WITH HIGH-DOSE METHOTREXATE-INDUCED NEPHROTOXICITY AND ACUTE-RENAL-FAILURE

      Leukemia & lymphoma
    11. RIBRAG V; NASR F; BOUHRIS JH; BOSQ J; BRAULT P; GIRINSKY T; COSSET JM; MUNCK JN; CORTI C; DECAUDIN D; PICO JL; HAYAT M; CARDE P
      VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE

      Bone marrow transplantation
    12. CASTAGNA L; ELWESHI A; BOURHIS JH; RIBRAG V; NACCACHE P; VANTELON JM; BRAULT P; PICO JL
      SUCCESSFUL DONOR-LYMPHOCYTE-INFUSION (DLI) IN A ATIENT WITH MYELODYSPLASTIC-SYNDROME (MDS) AFTER FAILURE OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION (TD-BMT)

      British Journal of Haematology
    13. El Weshi, A; Ribrag, V; Girinski, T; El Hajj, M; Dhermain, F; Bayle, C
      Low and medium dose spleen radiation therapy are able to induce long-term responses in splenic lymphoma with villous lymphocytes

      BRITISH JOURNAL OF HAEMATOLOGY
    14. DECAUDIN D; BOSQ J; MUNCK JN; BAYLE C; KOSCIELNY S; BOUDJEMAA S; BENNACEUR A; VENUAT AM; NACCACHE P; BENDAHMANE B; RIBRAG V; CARDE P; PICO JL; HAYAT M
      MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES

      Leukemia & lymphoma
    15. NASR F; MACINTYRE E; VENUAT AM; BAYLE C; CARDE P; RIBRAG V
      TRANSLOCATION T(4-11)(Q21-Q23) AND MLL GENE REARRANGEMENT IN ACUTE LYMPHOBLASTIC-LEUKEMIA SECONDARY TO ANTI TOPOISOMERASE-II ANTICANCER AGENTS

      Leukemia & lymphoma
    16. MASSAADMASSADE L; RIBRAG V; MARIE JP; FAUSSAT AM; BAYLE C; DREYFUS F; GOUYETTE A
      GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE

      Anticancer research
    17. SALABELLE A; RIBRAG V; NASR F; PAUTIER P; CORTI C; ELHAJJ M; LHOMME C; BAYLE C; BENNACEURGRISCELLI A
      ACTIVATED PROTEIN-C RESISTANCE IS RARELY ASSOCIATED WITH THROMBOTIC EVENTS IN PATIENTS WITH OVARIAN-CANCER

      Blood
    18. GIRINSKY T; RIBRAG V; BOSQ J; KOSCIENLY S; MUNCK JN; CARDE P; PICO JL; LUBIN R; BOURHIS JH; DELARUE P
      PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS

      Blood
    19. RIBRAG V; NASR F; ELHAJJ M; BENNACEURGRISCELLI A; CORTI C; HAYAT M; CARDE P; BAYLE C
      CLONAL CD3(-ASSOCIATED WITH B-CELL NHL OR HD AT RELAPSE - REPORT OF 3CASES() LARGE GRANULAR LYMPHOCYTES (LGL) PROLIFERATION)

      Blood
    20. RIBRAG V; TOUITOU R; BOSQ J; KOSCIELNY S; OUABDESSELAM R; NASR F; CORTI C; BRAULT P; CARDE P; HAYAT M; JOAB I; PALLARDY M
      HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    21. TURHAN AG; RIBRAG V; NOVAULT S; BONNET ML; VANTELON JM; LEFRERE F; VARET B; COULOMBEL L; PFLUMIO F; LEMOINE FM
      CLONALITY ANALYSIS OF HUMAN MYELODYSPLASIA IN SCID NOD MOUSE/

      Blood
    22. RIBRAG V; ELHAJJ M; NASR F; BAYLE C; LECHEVALIER T; LESCENE A; GATINEAU M; BENNACEURGRISCELLI A
      RT-PCR DETECTION OF PGP-9.5 M-RNA IN BONE-MARROW BLOOD-SAMPLES IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA

      Blood
    23. TORDJMAN R; MACINTYRE E; EMILE JF; VALENSI F; RIBRAG V; BURTIN ML; VARET B; BROUSSE N; HERMINE O
      AGGRESSIVE ACUTE CD3(-) T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA WITH 2 STAGES OF MATURATION ARREST(), CD56()

      Leukemia
    24. RIBRAG V; MASSADE L; FAUSSAT AM; DREYFUS F; BAYLE C; GOUYETTE A; MAIRE JP
      DRUG-RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia
    25. CORTI C; THEODORE C; BAYLE C; ROUGIER P; NASR F; COSSET JM; GIRINSKY T; HAYAT M; RIBRAG V
      HIGH-INCIDENCE OF SECONDARY MYELODYSPLASTIC SYNDROMES FOLLOWING PROMACE-MOPP AND INVOLVED FIELD RADIOTHERAPY FOR LOCALIZED GASTRIC NON-HODGKINS-LYMPHOMAS

      Hematological oncology
    26. BUZYNVEIL A; BELANGER C; AUDAT F; HERMINE O; BODEMER C; RIBRAG V; RADFORD I; POIREL H; CHANE C; VALENSI F; MACINTYRES E; VARET B
      SUSTAINED COMPLETE CYTOLOGIC AND MOLECULAR REMISSION INDUCED BY DONORLEUKOCYTE INFUSIONS ALONE IN AN ACUTE MYELOBLASTIC-LEUKEMIA IN RELAPSE AFTER BONE-MARROW TRANSPLANTATION

      British Journal of Haematology
    27. NASR F; CORTI C; CARDE P; RIBRAG V; VALENSI F; BAYLE C; TURHAN AG; BOSQ J
      CARCINOMA CELL LEUKEMIA

      Blood
    28. RIBRAG V; MASSAAD L; JANOT F; MORIZET J; GOUYETTE A; CHABOT GG
      MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY

      Leukemia & lymphoma
    29. GABARRE J; LEPAGE E; THYSS A; TUBIANA R; BASTION Y; SCHLAIFER D; SEBBAN C; RIBRAG V; FERERES M; RAPHAEL M; GISSELBRECHT C
      CHEMOTHERAPY COMBINED WITH ZIDOVUDINE AND GM-CSF IN HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKINS-LYMPHOMA

      Annals of oncology
    30. BOUSCARY D; PREUDHOMME C; RIBRAG V; MELLE J; VIGUIE F; PICARD F; GUESNU M; FENAUX P; GISSELBRECHT S; DREYFUS F
      PROGNOSTIC VALUE OF C-MPL EXPRESSION IN MYELODYSPLASTIC SYNDROMES

      Leukemia
    31. DREYFUS F; BOUSCARY D; MELLE J; RIBRAG V; GUESNU M; VARET B
      EXPRESSION OF THE EVI-1 GENE IN MYELODYSPLASTIC SYNDROMES

      Leukemia
    32. BLANCHE P; RIBRAG V; DREYFUS F; SICARD D
      CHRONIC LYMPHOID LEUKEMIA WITH BONE INVOL VEMENT

      La Presse medicale
    33. DREYFUS F; RIBRAG V; LEBLOND V; RAVAUD P; MELLE J; QUARRE MC; PILLIER C; BOCCACCIO C; VARET B
      DETECTION OF MALIGNANT B-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER CHEMOTHERAPY IN PATIENTS WITH MULTIPLE-MYELOMA

      Bone marrow transplantation
    34. BRAULT P; GILLES E; RIBRAG V; BOURHIS JH; MUNCK JN; PICO JL; HAYAT M
      SALVAGE TREATMENT OF RELAPSING LYMPHOMAS WITH A NON-MYELOTOXIC CHEMOTHERAPY COMBINING CISPLATINUM, BLEOMYCIN, METHYL GAG, AND PREDNISOLONE

      Bulletin du cancer
    35. RIBRAG V; MASSAAD L; JANOT F; BISSERY MC; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO

      Leukemia research
    36. LOPEZ I; GOUDOU C; RIBRAG V; SAUVAGE C; HAZEBROUCQ G; DREYFUS F
      THERAPY OF MUCOSITIS DURING ADMINISTRATIO N OF CHEMOTHERAPY WITH VITAMIN-E

      Annales de medecine interne
    37. RIBRAG V; DREYFUS F; VENOT A; LEBLONG V; LANORE JJ; VARET B
      PROGNOSTIC FACTORS OF INVASIVE PULMONARY ASPERGILLOSIS IN LEUKEMIC PATIENTS

      Leukemia & lymphoma
    38. RIBRAG V; DROZ JP; MORIZET J; LECLERCQ B; GOUYETTE A; CHABOT GG
      TEST DOSE-GUIDED ADMINISTRATION OF CISPLATIN IN AN ANEPHRIC PATIENT -A CASE-REPORT

      Annals of oncology
    39. RIBRAG V; SALMON D; PICARD F; GUESNU M; SICARD D; DREYFUS F
      INCREASE IN DOUBLE-POSITIVE CD4-CELL SUBSETS IN AN HIV-INFECTED PATIENT(CD8+ PERIPHERAL T)

      AIDS
    40. JANOT F; MASSAAD L; RIBRAG V; DEWAZIERS I; BEAUNE PH; LUBOINSKI B; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Carcinogenesis
    41. MASSAAD L; DEWAZIERS I; RIBRAG V; JANOT F; MORIZET J; BEAUNE PH; GOUYETTE A; CHABOT GG
      SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS

      Bulletin du cancer
    42. VIGON I; DREYFUS F; MELLE J; VIGUIE F; RIBRAG V; COCAULT L; SOUYRI M; GISSELBRECHT S
      EXPRESSION OF THE C-MPL PROTOONCOGENE IN HUMAN HEMATOLOGIC MALIGNANCIES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 14:22:37